Symrise AG (BIT:1SYM)

Italy flag Italy · Delayed Price · Currency is EUR
78.26
0.00 (0.00%)
Last updated: May 26, 2026, 9:00 AM CET
Market Cap11.28B -20.2%
Revenue (ttm)4.93B -1.4%
Net Income249.33M -47.9%
EPS1.78 -47.9%
Shares Out n/a
PE Ratio45.23
Forward PE21.14
Dividend1.25 (1.60%)
Ex-Dividend DateMay 7, 2026
Volumen/a
Open78.26
Previous Close78.26
Day's Range78.26 - 78.26
52-Week Range61.80 - 107.20
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateApr 29, 2026

About Symrise AG

Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates in two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; sweets, chocolate, chewing gum, baked goods, cereals, ice cream, milk, yogurt and mi... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 1874
Employees 12,971
Stock Exchange Borsa Italiana
Ticker Symbol 1SYM

Financial Performance

In 2025, Symrise AG's revenue was 4.93 billion, a decrease of -1.39% compared to the previous year's 5.00 billion. Earnings were 249.33 million, a decrease of -47.86%.

Financial Statements

News

EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Symrise AG Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 20.05.2...

8 days ago - Wallstreet:Online

EQS-DD: Symrise AG: Michael Friede, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.05.2026 / 09:59 CET/CEST The issuer is solely responsi...

23 days ago - Wallstreet:Online

Symrise AG Earnings Call Transcript: Q1 2026

Q1 2026 saw a slight organic sales decline but outperformed expectations, with strong growth in key segments and regions offsetting EMEA and Scent & Care weakness. Full-year guidance is reaffirmed, with sequential improvement and margin expansion expected.

4 weeks ago - Transcripts

Symrise AG Earnings release: Q1 2026

Symrise AG released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Symrise AG Slides: Q1 2026

Symrise AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.

4 weeks ago - Filings

Future Market Insights: Herb & Spice Extracts Market Outlook 2036 with Key Contributions from Givaudan, Kerry Group, McCormick & Company, Sensient Technologies, and Symrise

NEWARK, Del., April 29, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights (FMI), the global herb & spice extracts market is evolving into a critical ingredient...

4 weeks ago - Finanz Nachrichten

Symrise Q1 Sales Slip

HOLZMINDEN (dpa-AFX) - Symrise AG (SYIEF.PK, SYIEY.PK, SY1.DE), a German supplier of flavors, fragrances, cosmetics, and related products, on Wednesday reported a decline in sales for the first qu...

4 weeks ago - Finanz Nachrichten

Symrise AG Earnings Call Transcript: Q4 2025

2025 saw resilient organic growth, record profitability, and strong cash flow despite FX and market headwinds. Strategic transformation, portfolio optimization, and efficiency gains drove margin expansion, while 2026 guidance remains prudent amid macro uncertainty, with growth expected to accelerate in H2.

3 months ago - Transcripts

Symrise AG Annual report: Q4 2025

Symrise AG has published its Q4 2025 annual report on March 4, 2026.

3 months ago - Filings

Symrise AG Earnings release: Q4 2025

Symrise AG released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

3 months ago - Filings

Symrise AG Slides: Q4 2025

Symrise AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Symrise AG Earnings release: Q4 2025

Symrise AG released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

3 months ago - Filings

Symrise AG Slides: Q4 2025

Symrise AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Symrise AG Earnings Call Transcript: Q3 2025

Q3 2025 saw 1.4% organic sales growth, with strong performance in EMEA and food & beverage, but softness in North America and Latin America. Full-year growth guidance was lowered to 2.3%-3.3% amid macro headwinds, while cost savings and margin targets remain on track.

7 months ago - Transcripts

Symrise AG Earnings release: Q3 2025

Symrise AG released its Q3 2025 earnings on October 28, 2025, summarizing the period's financial results.

7 months ago - Filings

Symrise AG Slides: Q3 2025

Symrise AG has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 28, 2025.

7 months ago - Filings

Symrise and Aplantex Confirm an Agreement to Establish a Partnership

MONTREAL--(BUSINESS WIRE)--Symrise AG ("Symrise") and Aplantex Bio ("Aplantex") agree on a partnership covering new technologies for accessing plant-based molecules as raw material once the molecules ...

8 months ago - Business Wire

Symrise AG Earnings Call Transcript: Q2 2025

Solid H1 2025 results with 3.1% organic sales growth, 12% net income increase, and improved margins driven by efficiency gains and cost savings. Guidance for full-year organic growth was moderated to 2%-5%, but margin and cash flow targets were raised, reflecting confidence in ongoing transformation.

10 months ago - Transcripts

Symrise AG Quarterly report: Q2 2025

Symrise AG has published its Q2 2025 quarterly earnings report on July 30, 2025.

10 months ago - Filings

Symrise AG Slides: Q2 2025

Symrise AG has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 30, 2025.

10 months ago - Filings

Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP

HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a...

1 year ago - GlobeNewsWire